MENU
+Compare
VIR
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$9.57
Change
-$0.23 (-2.35%)
Capitalization
1.32B

VIR Vir Biotechnology Forecast, Technical & Fundamental Analysis

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VIR with price predictions
Feb 21, 2025

VIR sees its Stochastic Oscillator climbs out of oversold territory

On February 14, 2025, the Stochastic Oscillator for VIR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 61 instances where the indicator left the oversold zone. In of the 61 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for VIR moved above the 200-day moving average on February 07, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VIR advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

VIR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VIR as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VIR turned negative on January 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VIR entered a downward trend on February 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.062) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). VIR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (20.921) is also within normal values, averaging (251.218).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VIR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VIR is expected to report earnings to fall 44.07% to -87 cents per share on February 26

Vir Biotechnology VIR Stock Earnings Reports
Q4'24
Est.
$-0.87
Q3'24
Missed
by $0.51
Q2'24
Missed
by $0.13
Q1'24
Beat
by $0.57
Q4'23
Beat
by $0.22
The last earnings report on October 31 showed earnings per share of -155 cents, missing the estimate of -104 cents. With 712.71K shares outstanding, the current market capitalization sits at 1.32B.
A.I. Advisor
published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOSGX13.07N/A
N/A
Northern Small Cap Value
VRSGX32.11N/A
N/A
Virtus KAR Small-Cap Growth R6
KNGIX12.10-0.02
-0.17%
Vest S&P500 Div Aristocrats Trgt Inc Ins
MRSAX23.63-0.11
-0.46%
MFS Research International A
IRVSX32.93-0.39
-1.17%
Voya Russell Large Cap Value Idx Port S

VIR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-2.35%
SANA - VIR
61%
Loosely correlated
-1.63%
AXON - VIR
47%
Loosely correlated
-5.28%
GOSS - VIR
41%
Loosely correlated
-8.50%
CPRX - VIR
37%
Loosely correlated
-1.95%
IVVD - VIR
36%
Loosely correlated
+46.28%
More